HELLENIC DYNAMICS PLC Logo

HELLENIC DYNAMICS PLC

Cultivates and supplies THC-dominant medical cannabis for the European pharmaceutical market.

HELD | IL

Overview

Corporate Details

ISIN(s):
GB00BRXCFB77
LEI:
213800IM978BOB5QZA69
Country:
United Kingdom
Address:
21 ARLINGTON STREET, SW1A 1RN LONDON
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Hellenic Dynamics PLC is a licensed cultivator and supplier of pharmaceutical-standard medical cannabis products, specializing in THC-dominant strains. Founded in 2018, the company operates a large-scale cultivation and production facility near Thessaloniki, Greece, with significant capacity for dried cannabis flowers and extracts. Its license allows for unlimited production, export, and THC content. The company's primary target is the European medical market, with an initial focus on Germany, where its first production phase was pre-sold to licensed distributors. Hellenic Dynamics aims to become a dominant European supplier by offering high-quality, competitively priced products and developing a proprietary, IP-protected library of THC genetics through research partnerships.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-02-12 18:45
Legal Proceedings Report
Further re: Winding-Up Petition
English 14.4 KB
2024-12-19 12:35
Legal Proceedings Report
Further re: Winding-Up Petition
English 11.7 KB
2024-11-26 11:00
Legal Proceedings Report
Winding-Up Petition
English 11.8 KB
2024-11-15 08:00
Capital/Financing Update
Update on €1 million loan
English 11.4 KB
2024-11-11 14:30
Regulatory News Service
Change of Registered Office
English 9.0 KB
2024-10-07 08:00
Capital/Financing Update
Update on receipt of €1 million loan
English 10.5 KB
2024-08-21 16:30
Capital/Financing Update
Update on receipt of €1 million loan
English 10.4 KB
2024-08-14 08:00
Legal Proceedings Report
Update on Petition and Related Party Transactions
English 14.6 KB
2024-08-01 14:10
Legal Proceedings Report
Winding-Up Petition
English 10.8 KB
2024-08-01 09:00
Delisting Announcement
Delay to the publication of accounts & Suspension
English 12.7 KB
2024-07-15 08:00
Share Issue/Capital Change
Settlement of Fees and Issue of Equity
English 15.4 KB
2024-07-08 11:30
Major Shareholding Notification
Holding(s) in Company
English 52.3 KB
2024-07-02 16:18
Major Shareholding Notification
Holding(s) in Company
English 52.7 KB
2024-07-02 11:45
Regulatory News Service
Facility, Cultivation and Market Update
English 31.4 KB
2024-06-25 08:00
Board/Management Information
Directorate Changes
English 13.9 KB

Automate Your Workflow. Get a real-time feed of all HELLENIC DYNAMICS PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for HELLENIC DYNAMICS PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for HELLENIC DYNAMICS PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
BridgeBio Pharma, Inc. Logo
Develops transformative medicines for genetic diseases and genetically driven cancers.
United States of America BBIO
BRIGHT MINDS BIOSCIENCES INC. Logo
Developing next-gen serotonergic drugs for neurological and psychiatric disorders like epilepsy.
United States of America DRUG
BRISTOL MYERS SQUIBB CO Logo
Develops innovative medicines for oncology, immunology, and cardiovascular diseases.
United States of America BMY
R&D pharma firm developing drugs for CNS disorders, oncology, and metabolic diseases.
South Korea 003000
Burning Rock Biotech Ltd Logo
Offers NGS-based diagnostics for precision oncology, from detection to clinical trial support.
United States of America BNR
C4 Therapeutics, Inc. Logo
Developing protein degrader medicines to treat cancer and other serious diseases.
United States of America CCCC
Cabaletta Bio, Inc. Logo
Develops engineered T cell therapies for a curative reset in autoimmune diseases.
United States of America CABA
Cadrenal Therapeutics, Inc. Logo
Developing novel anticoagulant therapies for high-risk cardiovascular patients.
United States of America CVKD
CalciMedica, Inc. Logo
Develops CRAC channel inhibitors for critical illnesses like acute pancreatitis & AKI.
United States of America CALC
Calidi Biotherapeutics, Inc. Logo
Develops immunotherapies using stem cells to deliver oncolytic viruses against solid tumors.
United States of America CLDI

Talk to a Data Expert

Have a question? We'll get back to you promptly.